Infection Control market By Product Type (Sterilization Equipment {Low-Temperature Equipment, Heat Sterilization Equipment, Radiation Sterilization Equipment, Liquid Sterilization Equipment}, Disinfectors {Washer Disinfectors, Endoscope Repressors, Flusher Disinfectors, Surface Disinfectants, Hand Sanitizers}, Consumables {Sterilization Supplies, Protective Apparel & Textiles, Infectious Waste Disposal}), By Infection Type (Healthcare-Associated Infections (HAIs), Community-Associated Infections, Surgical Site Infections, Urinary Tract Infections, Bloodstream Infections, Others) By Technology (Automated Sterilization Systems, Ultraviolet (UV) Disinfection, Antimicrobial Coatings, Nanotechnology-based Solutions), By Route of Administration (Oral, Injectable, Topical, Others), and By End-user (Hospitals & Clinics, Long-Term Care Facilities, Pharmaceutical & Biotechnology Companies, Research Laboratories, Ambulatory Surgical Centers, Home Healthcare), Global Market Size, Segmental analysis, Regional Overview, Company shares analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Infection Control market accounted for USD 52.4 Billion in 2024 and is expected to reach USD 103.2 Billion by 2035, growing at a CAGR of around 6.35% between 2025 and 2035. Infectious control market refers to all types of goods, services, and technologies used to control infection in healthcare organizations. This encompasses sterilization equipment, disinfectants, personal protective equipment (PPE), hand sanitizers, and infection control software, among many others, in the quest to reduce the prevalence of healthcare-associated infections (HAIs) and improve patient safety. Major growth factors for the market encompass higher awareness of hygiene practices, regulatory requirements of infection control, technological advancements, and increased incidents of infectious diseases. Improving infection control measures shall further support expanded healthcare facility expansion and provide greater emphasis on clean and safe environments in healthcare services.

Report Scope:

Market Dynamics

Increasing Demand for Infection Control Measures Due to Rising Healthcare-Associated Infections (HAIs)

One major reason for increasing the requirement for strict infection control measures is the high rate of healthcare-associated infections or HAIs. According to the Centers for Disease Control and Prevention, about 1 in 31 patients who enter a hospital already harbor at least one form of HAI, which means that 1.7 million infections occur yearly in U.S. hospitals. These can lead to grave complications and longer hospital stays as well as higher healthcare bills. This growing incidence is mostly ascribed to invasive procedures, use of medical devices, and increased numbers of immunocompromised patients, therefore, there is an immense need for proper infection control strategies.

Education institutions and healthcare facilities stress the critical role of stringent infection control practices that can prevent HAIs. According to WHO, HAI results in about 90,000 deaths yearly in the USA, although the estimated cost of these infections is enormous. Rough estimates by the CDC put HAI at a cost of between $28.4 billion and $45 billion each year to the healthcare system in the United States

Enhanced Application of E-Beam Sterilization

The growth of the infection control market is mainly driven by the nature of the sterilizing agents and the variety of products available in terms of their susceptibility to heat. Some items of special interest include medical equipment and other materials used in processes such as autoclaving, sterilization by liquids, or radiation. E-beam or beta irradiation is widely used for the sterilization of medical devices and pharmaceutical packaging, although it is less suitable for the denser materials usually applied to low- to medium-density products. It has the advantage of relatively simple technology, which means the facility can be quickly activated and deactivated, and terminal sterilization occurs rapidly. E-beam sterilization usually takes only five to seven minutes, which inherently reduces the possible problems due to radiation compatibility. In addition, it reduces the risks associated with handling and thus the dangers involved. Overall, due to such innovations, growth in the infection control market is expected to become significant.

Challenges of High Endoscopy Reprocessing Costs and Limited Reimbursements in Developing Nations

Besides, the reprocessing of endoscopy is very costly, plus low reimbursement rates in developing countries. The reprocessing of endoscopes is expensive, the purchase of required pieces of equipment, maintenance, and cleaning supplies are expensive. In resource-constrained settings, this can be challenging for the healthcare provider. In addition, the meager reimbursement from the government in many developing countries adds to the cost burden on health facilities and places them under pressure to invest less in infection control efforts.

NCBI report, cost per colonoscopy ranged between US$188.64 at high-volume centers with 3000 annual procedures to US$501.16 at low-volume centers with 1000 annual procedures. Moreover, employee training and ongoing maintenance further add to higher expenses that, in general, gobble the effective management of endoscopy. Following that, endoscopy procedures remain highly expensive and especially in Asian countries, without any reimbursement from governments. As a result, their healthcare providers find cheaper alternatives instead. These issues drastically prevent comprehensive adoption of proper infection control measures in endoscopy procedures for developing nations.

Leveraging the Increase in Surgical Procedures to Enhance Infection Control Solutions.

Surgical interventions are now increasingly being performed globally. The Lancet Commission on Global Surgery, for instance, has in 2021 recommended that countries should have a minimum of up to 5,000 surgeries per 100,000 population and that a density of 20 specialist surgeons and surgical care providers per 100,000 individuals should be maintained for better coverage of surgical services. Some of the reasons for this rise include increasing percentages of obesity, lifestyle-related diseases, an aging population, and increasing cases of spinal and sport injuries. All these call for a heightened need in surgical equipment and medical appliances.

This growth in surgical activity herein calls to the need of being real about infection control measures. Infection control products and services demand will likely increase as the knowledge of infection prevention prevails in health care settings. In that context, as a greater number of surgeries are performed, good infection control practice is of significant importance because with it, risks of HAIs and SSIs can be controlled. A 2023 report by NCBI also commented that in the year 2021 there was a considerable surge of cosmetic procedures compared with previous years. Moreover, this trend underscores the urgency over strengthened infection controls, which will be one of the prime drivers in the adoption of infection control technologies and market growth in the coming years.

Capitalizing on the Opportunity in Wearable Infection Monitoring Devices

The rising attention of the governments toward public health and infection control manifests as one of the important opportunities for wearable infection monitoring devices. Reports by the U.S. Department of Health and Human Services, for instance, suggest that healthcare-associated infections affect nearly 1 in 31 patients within hospitals on any given day, causing nearly 72,000 deaths every year. Programs to be implemented on HAIs include, among others, Healthy People 2030 goals of which revolve around using the latest technology devices that may monitor significant vital signs and health metrics in real-time for patients, such as some wearables.

Additionally, it is described by the NIH that the ability to detect infections in their early stages can save as much as 30% of morbidity, indicating how productive these devices might be. Governments are investing in telehealth and other remote monitoring capacities, which helps them better manage public health-generating activities, especially against pandemics. These investments in reinforcement further strengthen market conditions: here companies are designing wearables that promise improvements in infection control and patient safety, a trend boosted further through increasing consumer interest in health-tracking devices.

Industry Experts Opinion

“The increasing prevalence of healthcare-associated infections underscores the urgent need for effective infection control measures. Without robust protocols and innovative technologies, we risk compromising patient safety and outcomes,”

• Dr. Emily Tran, infection control specialist at St. Mary’s Hospital, London.

Segment Analysis

Based on product type, the infection control market is classified into sterilization equipment and associated products. The equipment segment includes low-temperature equipment, heat sterilization equipment, radiation sterilization equipment, and liquid sterilization equipment. The disinfectors market also encompasses several varieties of disinfector products, such as washer disinfectors, endoscope repressors, and flusher disinfectors. Other important elements in this category include surface disinfectants and hand sanitizers. Consumables in the form of sterilization supplies, protective apparel and textiles, and solutions for infectious waste disposal are also included in the segment and are centrally important to effective infection control strategies.

Based on infection type, the Infection Control market is classified into Healthcare-Associated Infections (HAIs), Community-Associated Infections, Surgical Site Infections, Urinary Tract Infections, Bloodstream Infections, and Others. HAIs are acquired during healthcare procedures, while Community-Associated Infections occur outside of healthcare settings. Surgical Site Infections develop post-surgery, and Urinary Tract Infections result from bacteria entering the urinary system. Bloodstream Infections are severe infections caused by pathogens in the bloodstream, with Others encompassing various fewer common infections.

Based on technology, the Infection Control market includes Automated Sterilization Systems, Ultraviolet (UV) Disinfection, Antimicrobial Coatings, and Nanotechnology-based Solutions. Automated Sterilization Systems enhance efficiency, while UV Disinfection effectively eliminates pathogens with UV light. Antimicrobial Coatings offer lasting protection against microbes, and Nanotechnology-based Solutions leverage nanoparticles for advanced antimicrobial properties, improving infection control efforts.

Regional Analysis

The North American infection control market is a critical segment of the health care industry, characterized by high growth due to the escalating incidence of health care-acquired infections, increased awareness of hygiene practices, and stringent regulatory requirements. With heightened spending in the U.S. and Canada for health care, the market is poised to expand considerably with more investments in advanced infection control technologies. This includes the automated sterilization system and UV disinfection among others to enhance infection control practices.

Additionally, strict guidelines from agencies like the CDC and OSHA require tight infection control protocols in all healthcare settings. However, a challenge here in that high costs are associated with advanced technologies, and also many healthcare workers are ignorant or untrained in the market. The North American infection control market is expected to continue its expansion due to ongoing innovations, increasing regulatory pressure, and a growing emphasis on patient safety.

The rate of Asia Pacific is high and rapidly growing mainly due to factors such as large and diverse populations, increased rates of health care-associated infections (HAIs), and increased emphasis on hygiene because of increased urbanization and industrialization. Countries like Singapore, Malaysia, India, and China are also building more healthcare facilities, thereby increasing the demand for effective infection prevention technologies. The area is also witnessing an expanding middle-class population along with an increasing number of health-conscious consumers, and thus the demand for better infection control is on the rise. While innovations in technologies-such as mobile health applications and new disinfection methods-are beginning to emerge, factors such as varying health infrastructure and uneven regulatory practices within multiple countries hinder progress. Despite this, the Asia Pacific market holds much promise for growth a reflection of the region's commitment to quality health care and safe practices in response to changing challenges in public health.

Competitive Landscape

Key players in the infection control market are STERIS PLC (Cantel Medical Corporation), Belimed AG, Matachana Group, Halyard Health Inc. (Owens & Minor), Ecolab Inc., and Miele Group (Steelco). The company's focus on the most innovative sterilization and disinfection solutions meant to combat healthcare-related infections. Some of the recent collaborations indicate the way forward by the industry to incorporate sophisticated technology into their service portfolios. For instance, STERIS has lately teamed up with Wellspring Capital Management for further enhancement of sterilization services. Similarly, Halyard Health has partnered with Germitec for incorporating UV disinfection technology into their portfolio.

Ecolab has partnered with MediLogic for developing comprehensive cleaning protocols and Matachana has signed an agreement with Sonic Healthcare for its entry into new markets. These strategic alliances will not only add more selections of goods to the market but also enhance infection control in healthcare settings.

Infection Control market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In November 2023, a research team at Washington State University developed an innovative 3D-printed surgical tool that, in lab trials, proved to be effective in killing 87% of the bacteria that cause staph infections.

• In September 2023, Sodexo and Ecolab joined forces to challenge hospital-acquired infections (HAIs) through Ecolab's Bioquell hydrogen peroxide vapor technology to reduce the risk of disease in healthcare.

Report Coverage:

By Product Type

• Sterilization Equipment
  • Low-Temperature Equipment
  • Heat Sterilization Equipment
  • Radiation Sterilization Equipment
  • Liquid Sterilization Equipment
• Disinfectors
  • Washer Disinfectors
  • Endoscope Repressors
  • Flusher Disinfectors
  • Surface Disinfectants
  • Hand Sanitizers
• Consumables
  • Sterilization Supplies
  • Protective Apparel & Textiles
  • Infectious Waste Disposal

By Infection Type

• Healthcare-Associated Infections (HAIs)
• Community-Associated Infections 
• Surgical Site Infections 
• Urinary Tract Infections 
• Bloodstream Infections 
• Others

By Technology

• Automated Sterilization Systems 
• Ultraviolet (UV) Disinfection
• Antimicrobial Coatings
• Nanotechnology-based Solutions

By Route of Administration

• Oral 
• Injectable 
• Topical 
• Others

By End-user

• Hospitals & Clinics
• Long-Term Care Facilities
• Pharmaceutical & Biotechnology Companies 
• Research Laboratories
• Ambulatory Surgical Centers
• Home Healthcare

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• STERIS PLC (Cantel Medical Corporation)
• Belimed AG
• Matachana Group
• Halyard Health Inc.
• Ecolab Inc.
• Miele Group. (Steelco)
• MMM Group
• Pal Internation
• Metrex Research
• Sotera Health Inc.
• 3M Company
• Matachana Group
• Steris Corporation
• Reckitt Benckiser
• Getinge Group

Frequently Asked Questions (FAQs)